Mails to Aurobindo, Blackstone and Baring PE Asia did not generate a response as of press time Friday. Eugia consists of general injectable, oncology injectable, oncology oral solids, and hormonals. In the last three months, Aurobindo's stock has fallen 22%, underperforming the Nifty Pharma Index which is down 10.46% and the benchmark Nifty 50 which slipped 8.7%.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/t2HAna0
via IFTTT
0 comments:
Post a Comment